ImmunologyScientific ReportsPeer-reviewed
Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts
Farhana Jahan, Leena Penna, Annu Luostarinen…·Erja Kerkelä
This paper describes a GMP-compliant protocol for producing potent NK cells against AML and neuroblastoma using an automated platform, showing increased activation and killing efficacy.
16 citations